"Zhejiang Pharmaceuticals" anti-tumor new drug will enter Phase I clinical trial
-
Last Update: 2020-07-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Zhejiang Pharmaceutical Co., Ltdreceived on October 12, 2007 the State FoodDrugSupervision Administration on chemicaldrugsclass 1 new drug methfonateandinib and its tablets clinical trial approval, the product is the company's independent development and with independent intellectual property rights and PCT patent anti-
tumornew drug, there is no similar products in the worldThe product is about to enter Phase I clinical trials, but there is significant uncertainty from clinical trials to whether they will be available
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
